MedPath

RILUZOL AUROVITAS 50 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG

RILUZOL AUROVITAS 50 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG

Commercialized
Register Number

75160

Prescription Type

Uso Hospitalario

Authorization Date

Feb 22, 2012

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number75160
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

RILUZOLActive
Quantity: 50,0 mg
Name: RILUZOL

ATC CLASSIFICATION (3)

N07X
N07XX
N07XX02

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.